Papers - HAYAKAWA Yoshihiro

Mesenchymal-transitioned cancer cells instigate epithelial cancer cells to metastasis through secretion of WNT3 and WNT5B.

Kato S., Hayakawa Y., Sakurai H., Saiki I. and Yokoyama S.

Cancer Sci.   105   281 - 289   2014

Joint Work

Identification of plant extracts sensitizing breast cancer cells to TRAIL.

Abdelhamed S., Yokoyama S., Hafiyani L., Kalauni S.L., Hayakawa Y., Awale S., and Saiki I

Oncol. Rep   29   1991 - 1998   2013

Joint Work

Procyanidin C1 from Cinnamomi Cortex inhibits TGF-β-induced epithelial- to-mesenchymal transition in A549 lung cancer cell lines

Kin R., Kato S., Kaneto N., Sakurai H., Hayakawa Y., Li Feng., Tanaka K., Saiki I. and Yokoyama S

Int. J. Oncol   43   1901 - 1906   2013

Joint Work

Herbal medicine goshajinkigan prevents paclitaxel-induced mechanical allodynia without impairing anti-tumor activity of paclitaxel.

Bahar M.A., Andoh T., Ogura K., Hayakawa Y., Saiki I. and Kuraishi Y

Evid. Based Complement Alternat. Med   849754   2013

Joint Work

Berberine enhances TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-mediated apoptosis in breast cancer

Refaat A., Abdelhamed S., Yagita H., Inoue H., Yokoyama S., Hayakawa Y. and Saiki I.

Oncol. Letts   6   840 - 844   2013

Joint Work

Functional roles of TRAIL-DR5 interaction in B16F10 by activating NF-κB pathway to induce metastatic potential.

Takahashi K., Takeda K., Saiki I., Irimura T. and Hayakawa Y

Cancer Sci   104   558 - 562   2013

Joint Work